Anti-PD-L1 antibody retains antitumour effects while mitigating immunotherapy-related colitis in bladder cancer-bearing mice after CT-mediated intratumoral delivery

Wang, Y.-S., Zheng, A.-H., Zhao, J.-W. et al. (11 more authors) (2024) Anti-PD-L1 antibody retains antitumour effects while mitigating immunotherapy-related colitis in bladder cancer-bearing mice after CT-mediated intratumoral delivery. International Immunopharmacology, 137. 112417. ISSN 1567-5769

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/. This is an author produced version of an article published in International Immunopharmacology. Uploaded in accordance with the publisher's self-archiving policy.

Keywords: Polymer; Local delivery; Controlled release; Anti-PD-L1 antibody; Colitis
Dates:
  • Published: 20 August 2024
  • Published (online): 18 June 2024
  • Accepted: 3 June 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Environment (Leeds) > School of Food Science and Nutrition (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Sep 2024 12:57
Last Modified: 11 Sep 2024 12:57
Published Version: https://www.sciencedirect.com/science/article/pii/...
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.intimp.2024.112417
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Accepted Version


Embargoed until: 18 June 2025

Filename: MS_colitis.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

file not available

Export

Statistics